Why Prostate Cancer Screening Is More Confusing Than Ever (opens in new tab)
In this episode, Dr\. Rena Malik, MD and Dr\. Scott Eggener explore the complexities of prostate cancer screening, discussing personalized risk assessment, PSA testing, and the evolving guidelines on when to start and stop screening\. They break down the latest advancements in biomarker and MRI technology, clarify the distinction between low-risk \"wimpy\" cancers and those requiring treatment, and emphasize the importance of shared decision-making between doctors and patients\. Listeners wil...
Read the original article